CervoMed Inc. Number of Reportable Segments
CervoMed Inc. (CRVO) reported Number of Reportable Segments of 100.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-07
- CervoMed Inc. number of reportable segments for the quarter ending 2026-03-31 was 100.00%.
- CervoMed Inc. number of reportable segments for fiscal 2025 was 100.00%.
- CervoMed Inc. number of reportable segments for fiscal 2015 was 100.00%.
pure
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 100.00% 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 100.00% 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 100.00% 10-K · filed 2026-03-13 | |||
| 2025-09-30 | 100.00% 10-Q · filed 2025-11-07 | |||
| 2015-12-31 | 100.00% 10-K · filed 2016-03-25 |
segment
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2014-12-31 | 1.00 segment 10-K · filed 2015-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |